Sensex Falls On North Korea Tensions; Pharma, Metal Shares Under Pressure
Indian shares fell on Friday, tracking Asian markets lower, as geopolitical tensions following another missile launch by North Korea dampened sentiment and as profit taking was seen in recent outperformers such as banks and pharma stocks.
Asian shares ex-Japan and U.S. stock futures dipped after Pyongyang fired a missile over Japan into the Pacific Ocean on Friday, demonstrating the reclusive state's defiance in the face of intensifying sanctions.
"The market sentiment is subdued following (North Korea's) missile launch and also consolidation seems to be happening across sectors, including pharma and banks," said Gaurang Shah, head investment strategist at Geojit Financial Services.
The broader NSE Nifty was down 0.33 percent at 10,052.75, while the benchmark BSE Sensex was 0.19 percent lower at 32,180.94 as of 1:50 pm.
Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd, which gained in the last three sessions, fell 1.65 percent and 1.94 percent, respectively.
The Nifty Pharma Index was down 1.19 percent, on track to break its three-day winning streak.
Private lender Axis Bank Ltd fell 0.90 percent after gaining more than 2 percent this month up to Thursday's close.
The Nifty Bank Index was 0.36 percent lower, and was set to post its first loss this week.
State-owned Oil and Natural Gas Corp Ltd however rose as much as 4.4 percent, the top percentage gainer on the NSE index, and in line to snap a three-session losing run.
Shares of Max Financial Services Ltd surged as much as 4.8 percent after at least seven block deals took place on the BSE early in the session.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.